Search Results - "Ippoliti, Micaela" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

by Zaja, Francesco, Battista, Marta Lisa, Pirrotta, Maria Teresa, Palmieri, Salvatore, Montagna, Michela, Vianelli, Nicola, Marin, Luciana, Cavallin, Margherita, Bocchia, Monica, Defina, Marzia, Ippoliti, Micaela, Ferrara, Felicetto, Patriarca, Francesca, Avanzini, Maria Antonietta, Regazzi, Mario, Baccarani, Michele, Isola, Miriam, Soldano, Franca, Fanin, Renato
Published in Haematologica (Roma) (01.06.2008)

Get full text

Journal Article

Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch

Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch

by Forconi, Francesco, Sahota, Surinder S., Raspadori, Donatella, Ippoliti, Micaela, Babbage, Gavin, Lauria, Francesco, Stevenson, Freda K.
Published in Blood (15.11.2004)

Get full text

Journal Article

Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients

Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients

by Raspadori, Donatella, Lauria, Francesco, Bocchia, Monica, Ippoliti, Micaela, Gozzetti, Alessandro, Pietrini, Alice, Aprile, Lara, Defina, Marzia, Gozzini, Antonella, Baratè, Claudia
Published in Leukemia Research and Treatment (01.01.2012)

Get full text

Journal Article

Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination

Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination

by Bocchia, Monica, Defina, Marzia, Aprile, Lara, Ippoliti, Micaela, Crupi, Rosaria, Rondoni, Michela, Gozzetti, Alessandro, Lauria, Francesco
Published in Nature reviews. Clinical oncology (01.10.2010)

Get full text

Journal Article

Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy

Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first‐line nilotinib therapy

by Defina, Marzia, Ippoliti, Micaela, Gozzetti, Alessandro, Abruzzese, Elisabetta, Castagnetti, Fausto, Crupi, Rosaria, Tiribelli, Mario, Breccia, Massimo, Salvucci, Marzia, Aprile, Lara, Baratè, Claudia, Gozzini, Antonella, Rosti, Gianantonio, Lauria, Francesco, Bocchia, Monica
Published in Cancer (01.11.2012)

Get full text

Journal Article

Evaluation of residual CD34 super(+)Ph super(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

Evaluation of residual CD34 super(+)Ph super(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy

by Defina, Marzia, Ippoliti, Micaela, Gozzetti, Alessandro, Abruzzese, Elisabetta, Castagnetti, Fausto, Crupi, Rosaria, Tiribelli, Mario, Breccia, Massimo, Salvucci, Marzia, Aprile, Lara, Barate, Claudia, Gozzini, Antonella, Rosti, Gianantonio, Lauria, Francesco, Bocchia, Monica
Published in Cancer (01.11.2012)

Get full text

Journal Article

Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance

Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance

by Breccia, Massimo, Bocchia, Monica, Cannella, Laura, Defina, Marzia, Ippoliti, Micaela, Loglisci, Giuseppina, Santopietro, Michelina, Lauria, Francesco, Alimena, Giuliana
Published in British journal of haematology (01.07.2010)

Get full text

Journal Article

Two Novel WT-1 Derived Peptides Induce CD4+ peptide–specific T Cell Proliferation in Patients with Myelodysplastic Syndrome (MDS)

Two Novel WT-1 Derived Peptides Induce CD4+ peptide–specific T Cell Proliferation in Patients with Myelodysplastic Syndrome (MDS)

by Bocchia, Monica, Ippoliti, Micaela, Defina, Marzia, Crupi, Rosaria, Tassi, Maristella, Rondoni, Michela, Gozzetti, Alessandro, Lauria, Francesco
Published in Blood (16.11.2008)

Get full text

Journal Article

Peptide-Vaccine Treatment Associated with TKI Therapy in Patients with CML Is Able to Induce Immunologic, Cytogenetic and Molecular Responses: a Single Center Experience with Long-Term Follow up

Peptide-Vaccine Treatment Associated with TKI Therapy in Patients with CML Is Able to Induce Immunologic, Cytogenetic and Molecular Responses: a Single Center Experience with Long-Term Follow up

by Abruzzese, Elisabetta, Trawinska, Malgorzata Monika, Coletta, Angela, Zaza, Serena, Giovagnorio, Roberta, Poeta, Giovanni Del, Ippoliti, Micaela, Marzia, Delfina, de Fabritiis, Paolo, Coco, Francesco Lo, Amadori, Sergio, Bocchia, Monica
Published in Blood (20.11.2009)

Get full text

Journal Article

CMLVAX100 Peptide Vaccinations induce Peptide Specific “cytotoxic” CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response

CMLVAX100 Peptide Vaccinations induce Peptide Specific “cytotoxic” CD4+ T Cells (CD4+CTLs) in Chronic Myeloid Leukemia Patients: New Insights about Peptide Vaccine-Mediated Antitumor Response

by Bocchia, Monica, Tassi, Maristella, Ippoliti, Micaela, Defina, Marzia, Abruzzese, Elisabetta, Trawinska, Malgorzata Monika, Gozzetti, Alessandro, Raspadori, Donatella, Lauria, Francesco
Published in Blood (16.11.2008)

Get full text

Journal Article

Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy

Evaluation of Residual CD34+/Ph+ Stem Cells In Chronic Myeloid Leukemia Patients In Complete Cytogenetic Response during First Line Nilotinib Therapy

by Bocchia, Monica, Defina, Marzia, Ippoliti, Micaela, Abruzzese, Elisabetta, Castagnetti, Fausto, Tiribelli, Mario, Rosti, Gianantonio, Breccia, Massimo, Trawinska, Malgorzata Monika, Crupi, Rosaria, Aprile, Lara, Salvucci, Marzia, Baratè, Claudia, Gozzini, Antonella, Rondoni, Michela, Zaccaria, Alfonso, Alimena, Giuliana, Santini, Valeria, Specchia, Giorgina, Fanin, Renato, Gozzetti, Alessandro, Lauria, Francesco
Published in Blood (19.11.2010)

Get full text

Journal Article

Characterization of CD4+ T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients

Characterization of CD4+ T Cell Response Induced by p210-Derived Peptide Vaccinations in CML Patients

by Bocchia, Monica, Ippoliti, Micaela, Abruzzese, Elisabetta, Tassi, Maristella, Defina, Marzia, Trawinska, Malgorzata M., Gozzetti, Alessandro, Raspadori, Donatella, Lauria, Francesco
Published in Blood (16.11.2007)

Get full text

Journal Article

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a Phase 2 Multicenter GIMEMA CML Working Party Trial

by Bocchia, Monica, Defina, Marzia, Ippoliti, Micaela, Amabile, Marilina, Breccia, Massimo, Iuliano, Francesco, Vignetti, Marco, Gugliotta, Gabriele, Rossi, Antonella Russo, Alimena, Giuliana, Aprile, Lara, Gaidano, Gianluca, Nicoli, Paolo, Trawinska, Malgorzata Monika, Bassan, Renato, Turri, Diamante, Cannella, Laura, Luciano, Luigia, Gozzetti, Alessandro, Rondoni, Michela, Rosti, Gianantonio, Martinelli, Giovanni, Baccarani, Michele, Lauria, Francesco
Published in Blood (20.11.2009)

Get full text

Journal Article

Low Dose Rituximab in Adult Patients with Idiopathic Thrombocytopenic Purpura

Low Dose Rituximab in Adult Patients with Idiopathic Thrombocytopenic Purpura

by Zaja, Francesco, Battista, Marta L., Pirrota, Maria T., Palmieri, Salvatore, Montagna, Michela, Vianelli, Nicola, Cavallin, Margherita, Bocchia, Monica, Defina, Marzia, Ippoliti, Micaela, Ferrara, Felicetto, Patriarca, Francesca, Avanzini, Maria A., Regazzi, Mario, Isola, Miriam, Soldano, Franca, Baccarani, Michele, Fanin, Renato
Published in Blood (16.11.2007)

Get full text

Journal Article

Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate

Evaluation of Ph+/CD34+ Residual Cells in Chronic Myeloid Leukemia Patients after Long Lasting Treatment with Imatinib Mesylate

by Bocchia, Monica, Abruzzese, Elisabetta, Ippoliti, Micaela, Calabrese, Simona, Gozzetti, Alessandro, Pirrotta, Maria Teresa, Crupi, Rosaria, Tozzuoli, Daniela, Lauria, Francesco
Published in Blood (16.11.2005)

Get full text

Journal Article

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial

Control of Residual Disease in Imatinib Treated Chronic Myeloid Leukemia Patients with Peptide Vaccinations: 2 Years Follow up of CMLVAX100 Trial

by Bocchia, Monica, Abruzzese, Elisabetta, Ippoliti, Micaela, Pirrotta, Maria Teresa, Trawinska, Malgorzata M., Amabile, Marilina, Martinelli, Giovanni, Forconi, Francesco, Gozzetti, Alessandro, Carella, Angelo M., Raspadori, Donatella, Lauria, Francesco
Published in Blood (16.11.2005)

Get full text

Journal Article

Antibody binding capacity for evaluation of MDR‐related proteins in acute promyelocytic leukemia: Onset versus relapse expression

Antibody binding capacity for evaluation of MDR‐related proteins in acute promyelocytic leukemia: Onset versus relapse expression

by Damiani, Daniela, Michieli, Mariagrazia, Michelutti, Angela, Candoni, Anna, Stocchi, Raffaella, Masolini, Paola, Geromin, Antonella, Michelutti, Teresa, Raspadori, Donatella, Ippoliti, Micaela, Lauria, Francesco, Fanin, Renato
Published in Cytometry. Part B, Clinical cytometry (01.05.2004)

Get full text

Journal Article

Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance

Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance

by Breccia, Massimo, Bocchia, Monica, Cannella, Laura, Defina, Marzia, Ippoliti, Micaela, Loglisci, Giuseppina, Santopietro, Michelina, Lauria, Francesco, Alimena, Giuliana
Published in British journal of haematology (01.07.2010)

Get full text

Report